透析市場規模、佔有率、成長分析，按類型、按產品/服務、按最終用戶、按地區 - 行業預測，2024-2031

2022年全球透析市場規模將為1108億美元，從2023年的1158.2億美元成長到2031年的1624.5億美元，在預測期內（2024-2031年）預計複合年成長率為4.32%。

由於慢性腎臟病病率顯著增加，導致腎臟診所尋求治療的患者數量增加，透析市場正在強勁成長。這一趨勢得到了私人和政府機構收緊支付政策的支持，特別是美國醫療保險和醫療補助服務中心 (CMS)。例如，2019 年，CMS 向約 7,000 名末期腎病 (ESRD) 提供者分配了約 103 億美元的醫療保險報銷，以支付血液透析機費用。預計此類財務支持將在未來幾年刺激市場擴張。據美國國立衛生研究院（NIH）稱，約5%的新冠患者需要腎臟替代治療，許多重症患者患有急性腎損傷。為了滿足這些迫切需求，醫院擴大引進腎臟治療設備，進一步推動了市場的成長軌跡。因此，美國市場情勢預計將呈現持續成長，並有望在預測期內實現穩定的複合年成長率。這反映了腎臟相關疾病緊迫的醫療需求和不斷變化的治療前景。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 專利分析
• 技術分析
• 監管環境

透析市場：按類型

• 市場概況
• 血液透析機
  • 傳統血液透析機
  • 短期透析
  • 夜間血液透析機
• 腹膜透析
  • 連續性攜帶式腹膜透析 (CAPD) 透析
  • 自動腹膜透析（APD）

透析市場：依產品/服務分類

• 市場概況
• 服務
• 裝置
  • 透析設備
  • 水療系統
  • 其他
• 消耗品
  • 透析設備
  • 導管
  • 其他
• 透析藥物

透析市場：依最終用戶分類

• 市場概況
• 中心透析
• 家庭透析治療

透析市場規模：按地區分類

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Asahi Kasei Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton Dickinson and Company
• DaVita Inc.
• Fresenius Medical Care AG & Co. KGaA
• JMS Co. Ltd.
• Medtronic plc
• Nikkiso Co. Ltd.
• NIPRO Corporation
• Satellite Healthcare Inc.
• Toray Industries Inc.
• Diaverum Deutschland GmbH
• NxStage Medical, Inc.
• Rockwell Medical Technologies, Inc.
• AllMed Medical GmbH
• Fresenius Kabi AG
• Quanta Dialysis Technologies Ltd.
• Outset Medical, Inc.
• Medica SpA

Global Dialysis Market size was valued at USD 110.80 billion in 2022 and is poised to grow from USD 115.82 billion in 2023 to USD 162.45 billion by 2031, growing at a CAGR of 4.32% during the forecast period (2024-2031).

The dialysis market is experiencing robust growth due to a significant rise in chronic kidney disease prevalence, leading to more patients seeking treatment at renal clinics. Enhanced payment policies from commercial and government entities, particularly the Centers for Medicare & Medicaid Services (CMS), support this trend; for instance, in 2019, CMS allocated roughly US$ 10.3 billion in Medicare reimbursements to around 7,000 end-stage renal disease (ESRD) providers to cover hemodialysis costs. This financial backing is expected to fuel market expansion in the coming years. Additionally, the recent COVID-19 pandemic has exacerbated the demand for renal equipment, as many critically ill patients suffer from acute kidney injury, with about 5% of COVID cases requiring renal replacement therapy according to the National Institutes of Health (NIH). Hospitals are increasingly adopting renal therapy equipment to meet this urgent need, further driving the market's growth trajectory. As a result, the US dialysis market is positioned for sustained growth, projected to achieve a consistent compound annual growth rate (CAGR) in the upcoming forecast period, reflecting both the pressing healthcare demands and the evolving treatment landscape for kidney-related disorders.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dialysis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dialysis Market Segmental Analysis

Global Dialysis Market is segmented by Type, Products and Services, End User, and Region. Based on Type, the market is segmented into Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)). Based on Products and Services, the market is segmented into Services, Equipment (Dialysis Machines, Water Treatment Systems, Others), Consumables (Dialyzers, Catheters, Others), Dialysis Drugs. Based on End User, the market is segmented into In-center Dialysis, Home Dialysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dialysis Market

The escalating prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) is a significant market driver for the global dialysis market. As the burden of ESRD increases, necessitating long-term renal therapies or transplants, healthcare systems face immense financial pressures, thereby escalating the demand for efficient dialysis services. With approximately 15% of the U.S. population affected by CKD, the urgency for accessible renal care is heightened. Additionally, the expansion of nephrology specialists and renal care facilities in developed nations, coupled with investments aimed at establishing dialysis centers in emerging markets like India and China, underscores a robust growth trajectory. This demand for affordable yet effective renal treatments is projected to fuel substantial market revenue generation, making it a pivotal factor in the global dialysis landscape.

Restraints in the Global Dialysis Market

The global dialysis market faces significant restraint due to the growing preference for kidney transplantation as a treatment for end-stage renal disease (ESRD) and stage III chronic kidney disease (CKD). Patients often opt for transplantation over dialysis, attracted by the potential for better long-term outcomes and improved quality of life. Favorable reimbursement policies make kidney transplantation a more financially viable option, further driving this shift. Additionally, the rising costs associated with renal therapy, exacerbated by the coronavirus pandemic-especially in countries like India-may deter patients from opting for dialysis, ultimately hindering market growth and adoption of dialysis treatments.

Market Trends of the Global Dialysis Market

The Global Dialysis market is witnessing a significant trend of transitioning from traditional clinic-based care to homecare settings, driven by patient preferences, especially in developed economies. This shift is complemented by government initiatives, particularly in the United States, aimed at promoting cost-effective home treatment options for end-stage renal disease (ESRD). The emergence of advanced renal care technologies, including innovative dialysis machines and efficient dialyzers, is further propelling market growth, with key players like B.Braun and Fresenius Kabi leading the charge in product development. The focus on enhancing accessibility to homecare is expected to attract a growing number of patients seeking convenient and personalized treatment options, heralding a transformative phase in the dialysis landscape.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Types
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Patent Analysis
• Technology Analysis
• Regulatory Landscape

Dialysis Market, By Type

• Market Overview
• Hemodialysis
  • Conventional Hemodialysis
  • Short Daily Hemodialysis
  • Nocturnal Hemodialysis
• Peritoneal Dialysis
  • Continuous Ambulatory Peritoneal Dialysis (CAPD)
  • Automated Peritoneal Dialysis (APD)

Dialysis Market, By Products and Services

• Market Overview
• Services
• Equipment
  • Dialysis Machines
  • Water Treatment Systems
  • Others
• Consumables
  • Dialyzers
  • Catheters
  • Others
• Dialysis Drugs

Dialysis Market, By End User

• Market Overview
• In-center Dialysis
• Home Dialysis

Dialysis Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DaVita Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care AG & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JMS Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NIPRO Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Satellite Healthcare Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toray Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diaverum Deutschland GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NxStage Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rockwell Medical Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AllMed Medical GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quanta Dialysis Technologies Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Outset Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica S.p.A
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments